BRIEF published on 11/05/2025 at 18:24, 4 months 10 days ago Leadership Transition at SCHOTT Pharma: Christian Mias Appointed CEO SCHOTT Pharma Leadership Transition Executive Appointment Pharmaceutical Growth Christian Mias
PRESS RELEASE published on 11/05/2025 at 18:19, 4 months 10 days ago SCHOTT Pharma: Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma Christian Mias appointed as CEO of SCHOTT Pharma, succeeding Andreas Reisse. Strategic leadership transition ensured for global pharmaceutical packaging leader Pharmaceutical SCHOTT Pharma CEO Christian Mias Andreas Reisse
BRIEF published on 11/05/2025 at 18:01, 4 months 10 days ago Christian Mias Appointed as New CEO of SCHOTT Pharma CEO Appointment SCHOTT Pharma Leadership Change Christian Mias Andreas Reisse
PRESS RELEASE published on 11/05/2025 at 17:56, 4 months 10 days ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO SCHOTT Pharma AG & Co. KGaA appoints Christian Mias as CEO to succeed Andreas Reisse, effective May 1, 2026. Inside information disclosed. Press release via EQS News Inside Information CEO Appointment SCHOTT Pharma EQS News Christian Mias
BRIEF published on 08/12/2025 at 07:05, 7 months 4 days ago SCHOTT Pharma Reports Steady Q3 2025 Results Innovation SCHOTT Pharma High-value Solutions Drug Containment Q3 2025 Results
PRESS RELEASE published on 08/12/2025 at 07:00, 7 months 4 days ago SCHOTT Pharma delivers solid final third-quarter results SCHOTT Pharma reports solid Q3 2025 results with 1% revenue growth, 32.4% EBITDA margin, and strategic innovations Revenue Growth EBITDA Margin SCHOTT Pharma Innovations Q3 2025 Results
BRIEF published on 08/05/2025 at 10:00, 7 months 11 days ago SCHOTT Pharma's Q3 2025 Highlights and FY 2025 Outlook Revenue Growth EBITDA Margin Financial Outlook Q3 2025 High Value Solutions
BRIEF published on 08/05/2025 at 09:58, 7 months 11 days ago SCHOTT Pharma Updates FY 2025 Revenue and EBITDA Guidance Financial Results Revenue Growth EBITDA Margin SCHOTT Pharma FY 2025 Guidance
PRESS RELEASE published on 08/05/2025 at 09:55, 7 months 11 days ago SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance SCHOTT Pharma reports Q3 2025 revenues up 3% yoy at EUR 256m and gives FY 2025 guidance with EBITDA expected to be around 28.0%. Full financial results to be published on August 12, 2025 Revenues EBITDA SCHOTT Pharma Q3 2025 FY 2025 Guidance
PRESS RELEASE published on 08/05/2025 at 09:53, 7 months 11 days ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma specifies FY 2025 guidance for revenue growth and EBITDA margin SCHOTT Pharma AG & Co. KGaA specifies FY 2025 guidance for revenue growth and EBITDA margin, expecting 6.0% organic revenue growth and 28.0% EBITDA margin Revenue Growth EBITDA Margin SCHOTT Pharma Guidance FY 2025
Published on 03/16/2026 at 11:30, 3 minutes ago Relevant Gold Announces $15 Million Strategic Financing with Participation from Kinross, Bollinger, and McEwen
Published on 03/16/2026 at 11:00, 33 minutes ago Vox Royalty Announces Inclusion in MVIS(R) Global Junior Gold Miners Index and VanEck Junior Gold Miners ETF (GDXJ)
Published on 03/16/2026 at 11:00, 33 minutes ago Banyan Intercepts Several New Distinct High-grade Silver Veins, including 3,408 g/t Ag over 1.4 m, at AurMac, Yukon
Published on 03/15/2026 at 23:25, 12 hours 8 minutes ago Tunkillia 'Phase 2' Resource Upgrade Drilling Begins
Published on 03/15/2026 at 18:00, 17 hours 33 minutes ago SEG Announced 2025 Annual Results Initiating First Special Dividend Distribution Payout Ratio Reached 88% Newly Signed Orders Exceeded RMB100-Billion Mark for the Second Consecutive Year
Published on 03/16/2026 at 11:00, 33 minutes ago BIO-Europe Spring® 2026: Partnering Momentum Builds as Global Biopharma Leaders Set Course for Lisbon
Published on 03/16/2026 at 11:00, 33 minutes ago CTS EVENTIM: EVENTIM LIVE expands in the French live market with promoter Pierre-Alexandre Vertadier
Published on 03/16/2026 at 11:00, 33 minutes ago Vossloh to deliver high-speed grinding train to China
Published on 03/16/2026 at 11:00, 33 minutes ago Nebius signs new AI infrastructure agreement with Meta
Published on 03/16/2026 at 10:45, 47 minutes ago HKTDC Smart Lighting Expo and Hong Kong International Lighting Fair (Spring Edition) to open in April
Published on 03/16/2026 at 08:30, 3 hours 3 minutes ago CDA - Update on CDA' parks solarization program
Published on 03/13/2026 at 19:50, 2 days 15 hours ago Availability of ENGIE’S 2025 Universal Registration Document
Published on 03/13/2026 at 18:05, 2 days 17 hours ago Availability of the 2025 Universal Registration Document of OPmobility SE
Published on 03/13/2026 at 07:30, 3 days 4 hours ago BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Published on 03/12/2026 at 18:00, 3 days 17 hours ago NEW OR RENEWED AGREEMENTS BETWEEN EURAZEO AND CERTAIN FAMILY SHAREHOLDERS
